Sight Sciences (SGHT) Competitors

SI-BONE (NASDAQ:SIBN) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Does the MarketBeat Community believe in SIBN or SGHT?

SI-BONE received 152 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 68.80% of users gave SI-BONE an outperform vote while only 29.85% of users gave Sight Sciences an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 172 68.80%	Underperform Votes 78 31.20%
Sight Sciences	Outperform Votes 20 29.85%	Underperform Votes 47 70.15%

Do analysts rate SIBN or SGHT?

SI-BONE presently has a consensus price target of $24.40, indicating a potential upside of 78.36%. Sight Sciences has a consensus price target of $3.83, indicating a potential upside of 24.46%. Given SI-BONE's stronger consensus rating and higher possible upside, research analysts clearly believe SI-BONE is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sight Sciences	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29

Which has preferable earnings and valuation, SIBN or SGHT?

SI-BONE has higher revenue and earnings than Sight Sciences. SI-BONE is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$167.18M	3.47	-$43.34M	-$0.76	-18.00
Sight Sciences	$79.87M	1.99	-$55.55M	-$1.03	-2.99

Does the media prefer SIBN or SGHT?

In the previous week, SI-BONE had 1 more articles in the media than Sight Sciences. MarketBeat recorded 6 mentions for SI-BONE and 5 mentions for Sight Sciences. SI-BONE's average media sentiment score of 1.52 beat Sight Sciences' score of 0.73 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Sight Sciences	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, SIBN or SGHT?

SI-BONE has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.46, suggesting that its stock price is 146% more volatile than the S&P 500.

Do insiders and institutionals hold more shares of SIBN or SGHT?

98.1% of SI-BONE shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 3.9% of SI-BONE shares are owned by insiders. Comparatively, 28.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is SIBN or SGHT more profitable?

SI-BONE has a net margin of -23.82% compared to Sight Sciences' net margin of -63.30%. SI-BONE's return on equity of -22.51% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-23.82%	-22.51%	-16.53%
Sight Sciences	-63.30%	-47.28%	-32.72%

Summary

SI-BONE beats Sight Sciences on 15 of the 18 factors compared between the two stocks.